Searched for
EPCLUSA
NPPA lens on five pharma companies for Hepatitis C drug overchargeNPPA has sent show-cause notices to these companies alleging overcharging for the combination drug used to treat the potentially fatal Hepa...- Natco Pharma launches generic hepatitis C drug in IndiaThe company has launched a generic version of sofosbuvir 400 mg/velpatasvir 100 mg fixed dose combination in India under the brand name 'Ve...
- Hetero gets DCGI nod for generic chronic hepatitis C drugThe company "has received the approval for the generic version of 'Sofosbuvir+Velpatasvir' combination from the Drugs Controller General of...
- US’ Gilead faces competition from Bangladesh’s Beacon pharmaThe challenger Beacon produces first generic version of Gilead’s newly launched Epclusa — a drug used to treat all types of Hepatitis C.
- India may soon get treatment for Hepatitis CThe drug called Epclusa which is developed to treat all genotypes of the Hepatitis C virus by Gilead Sciences in its latest breakthrough tr...
Load More